Therapeutic Asset Ratings
1,055 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Dabrafenib
Lymphoproliferative Syndrome
Cancer Research UK
P2/3
B
(56)
Dabrafenib
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma
Cancer Research UK
P2/3
B
(56)
Dabrafenib
Thyroid Gland Papillary Carcinoma
Cancer Research UK
P2/3
B
(56)
Decitabine
Hodgkins Lymphoma
National Cancer Institute (NCI)
P2/3
B
(56)
Eltrombopag
Acute Myeloid Leukemia
French Innovative Leukemia Organisation
P2/3
B
(56)
Equine Atg
Sickle Cell Disease
University of Illinois at Chicago
P2/3
B
(56)
Glenzocimab
Ischemic Stroke
Fondation Ophtalmologique Adolphe de Rothschild
P2/3
B
(56)
HUMAN IMMUNOGLOBULINS
Leukemia
Monash University
P2/3
B
(56)
Imgn632
Acute Myeloid Leukemia
AbbVie
P2/3
B
(56)
Intralipid
Obesity Disorder
Yale University
P2/3
B
(56)
Oxygen
Neuralgia
Bernardino Clavo, MD, PhD
P2/3
B
(56)
PEGFILGRASTIM
Ovarian Carcinoma
TORL Biotherapeutics, LLC
P2/3
B
(56)
PHYSIOLOGIC SODIUM CHLORIDE SOLUTION
Cognitive Disorder
Nelly Pitteloud
P2/3
B
(56)
PHYSIOLOGIC SODIUM CHLORIDE SOLUTION
Down Syndrome
Nelly Pitteloud
P2/3
B
(56)
PHYSIOLOGIC SODIUM CHLORIDE SOLUTION
Secondary Progressive Multiple Sclerosis
Institute of Psychiatry and Neurology, Warsaw
P2/3
B
(56)
PHYSIOLOGIC SODIUM CHLORIDE SOLUTION
Olfactory Nerve Disorder
Nelly Pitteloud
P2/3
B
(56)
PIFLUFOLASTAT
Nonpapillary Renal Cell Carcinoma
Lantheus Medical Imaging
P2/3
B
(56)
S-1
Cancer
University of Malaya
P2/3
B
(56)
Si-B001
Non-Small Cell Lung Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
P2/3
B
(56)
Sirolimus
Prostate Cancer
Medical University of South Carolina
P2/3
B
(56)
Telisotuzumab Adizutecan
Non-Small Cell Lung Carcinoma
AbbVie
P2/3
B
(56)
Trametinib
Erdheim-Chester Disease
Cancer Research UK
P2/3
B
(56)
Trametinib
Langerhans Cell Histiocytosis
Cancer Research UK
P2/3
B
(56)
Trametinib
Laryngeal Neoplasm
Cancer Research UK
P2/3
B
(56)
Trametinib
Lymphoproliferative Syndrome
Cancer Research UK
P2/3
B
(56)
Showing 676 to 700 of 1,055 assets
Previous
Page 28 of 43
Next